China index futures midday close: main contracts - CSI 300 (IF) +1.42%; SSE 50 (IH) +0.80%; CSI 500 (IC) +0.39%; CSI 1000 (IM) +0.10%.

Kexing Group’s Beijing Kexing Zhongwei Biotechnology Co. has signed six task agreements under China’s national major science-and-technology program for emerging and major infectious-disease control. Projects cover vaccine and monoclonal antibody R&D against Dabie bandavirus, chikungunya, dengue and Zika viruses, plus research into mechanisms of severe disease from mosquito‑borne viruses and early intervention measures. The program prioritizes coordinated development of vaccines, therapeutics and key prevention technologies to meet national strategic needs in infectious-disease control.

Beijing, Jun 2 (Beijing time early hours) — At a UN Security Council emergency meeting on the Lebanon-Israel situation, China’s UN ambassador Fu Cong said the situation has sharply escalated: Israel has expanded military operations in Lebanon, widened a so‑called “security zone,” crossed the Litani River and occupied Beaufort Castle — its deepest incursion into Lebanon in more than 20 years. Fu said Israel has announced intentions to further expand ground operations and that the ceasefire is effectively dead, prompting serious international concern. China called for an immediate ceasefire and full Israeli withdrawal, increased support to Lebanon, and for UNIFIL to be enabled to carry out its mandate to preserve regional stability.